Rock Creek Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,196	Closed	-$192K	–	85
2018 Q3	$192K	Buy	+2,196	New	+$192K	0.08%	82